Disseminated herpes zoster infection in a patient with lymphoma

Immunosuppression facilitates varicella zoster virus (VZV) reactivation in immunocompromised patients. Atypical presentation such as disseminated disease of herpes zoster infection has been described in immunosuppressed patients. One of the best choices of therapy in herpes zoster infection is acyclovir, but long-term therapy may cause resistance to it. In this report a disseminated herpes zoster infection is described in a patient with T cell lymphoma after acyclovir/valacyclovir therapy. The infection was irresponsive to acyclovir and valacyclovir and we were unable to control the infection because it was not possible to obtain foscarnet and the patient died due to Staphylococcus epidermis sepsis.

[1]  S. Venkatachalapathy,et al.  Atypical presentation of varicella zoster in a patient on alemtuzumab , 2007, British journal of haematology.

[2]  D. Malvy,et al.  A retrospective, case-control study of acyclovir resistance in herpes simplex virus. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  E. De Clercq,et al.  In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? , 2004, Antiviral research.

[4]  J. Orange,et al.  Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. , 2003, The Journal of infectious diseases.

[5]  S. Paydaş,et al.  Hepatitis B Virus Reactivation During Fludarabine Therapy in Non-Hodgkin's Lymphoma , 2003, Leukemia & lymphoma.

[6]  David Sutton,et al.  Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy , 2003, Clinical Microbiology Reviews.

[7]  M. Boccadoro,et al.  Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma , 2001, Leukemia.

[8]  A. Fillet,et al.  ZONA RÉSISTANT À L'ACICLOVIR CHEZ UN MALADE IMMUNODÉPRIMÉ NON INFECTÉ PAR LE VIH , 1998 .

[9]  H. Kessler,et al.  Herpes simplex virus resistance to acyclovir: clinical relevance. , 1995, Infectious agents and disease.

[10]  N. Sadick,et al.  Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. , 1988, JAMA.

[11]  J. Huraux,et al.  [Acyclovir-resistance zona in a immunocompromised HIV seronegative patient]. , 1998, Annales de dermatologie et de venereologie.